Neuropeptides, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor-receptor interactions. Relevance for Parkinson's disease and schizophrenia.
Fuxe
K
K
Department of Histology and Neurobiology, Karolinska Institute, Stockholm, Sweden.
Agnati
L F
LF
von Euler
G
G
Tanganelli
S
S
O'Connor
W T
WT
Ferré
S
S
Hedlund
P
P
Zoli
M
M
D000818:Animals; D001479:Basal Ganglia / Q000378:metabolism; D006801:Humans; D009479:Neuropeptides / Q000502:physiology*; D010300:Parkinson Disease / Q000378:metabolism*; D051381:Rats; D017459:Receptors, Amino Acid / Q000502:physiology*; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D018047:Receptors, Purinergic P1 / Q000502:physiology*; D012559:Schizophrenia / Q000378:metabolism*
D009479:Neuropeptides; D017459:Receptors, Amino Acid; D017448:Receptors, Dopamine D2; D018047:Receptors, Purinergic P1